Approvals/TGA/SCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet blister pack

Approved

STANDARD

SCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet blister pack

Approval Id: f95087e68fb2b4cc
Product Name: SCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet blister pack
Artg Id: 371018
Artg Name: SCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet blister pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2022-07-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-01714-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01713-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f95087e68fb2b4cc

Type

Standard